Rights Financial News
21.02 / 02:21
Provident
DOW
Analysis
economy
Research
Trade
rights
Wall Street ends lower as weak Walmart guidance prompts consumer demand worries
Walmart dampened investor risk appetite. A broad selloff pulled all three major U.S. stock indexes into negative territory, with the blue-chip Dow suffering the steepest loss. The S&P 500 snapped its two-day string of all-time closing highs.
21.02 / 02:21
UPS
Analysis
Trade
President
War
track
rights
Trump tariff worries set gold on course for eighth straight weekly gain
Gold prices were little changed on Friday but remained on track for an eighth successive weekly gain, driven by concerns over U.S. President Donald Trump's tariff plans, which could spark trade wars and stoke inflation.
21.02 / 01:31
FIVE
security
Analysis
Research
trends
Trade
rights
Vedanta gets nod to split into five separate entities
Vedanta's proposed demerger plan of the unified business into separately listed verticals has received approval from its equity shareholders, and secured and unsecured creditors, the company said Thursday. This will allow the mining conglomerate to list its businesses — aluminum, oil & gas, power, steel — as separate units. At present, these businesses are subsumed within Vedanta, while Hindustan Zinc, which includes revenue streams from white metals zinc and silver, is listed separately. After the Merger, Vedanta will hold the Hindustan Zinc business.
21.02 / 01:31
markets
Analysis
Research
Bill
trends
Trade
rights
RBI to hold variable rate repo auction to infuse Rs 75,000 crore
This announcement for the VRR to be conducted at noon Friday comes on the day RBI received four times more bids under the bond purchase programme — or the open market operations (OMO) — the last among a host of liquidity infusion measures announced on January 27.
21.02 / 01:31
markets
Action
security
Analysis
trends
Trade
rights
Pre-market action: Here's the trade setup for today's session
Analysts expect Nifty to consolidate near its current levels in the absence of any fresh triggers, as it can be seen holding above 22,800-22,900 levels since the past seven trading sessions supported by buying at lower levels.
21.02 / 00:31
markets
security
Mobile
Analysis
trends
Trade
rights
Investors to access 'Direct' data from exchanges soon
fraudulent intervention by any person, a senior Sebi official said on Thursday. «As a regulator we often come across cases of investors who have been conned by frauds in the market, who claim that they have invested their monies on behalf of the investor but those funds have just been siphoned off,» Sebi chief Madhabi Puri Buch said at the launch of unified investor apps by depositories NSDL and CDSL.
21.02 / 00:31
20.02 / 20:27
20.02 / 20:27
20.02 / 17:58
20.02 / 16:03
20.02 / 10:21
Manufacturing
Analysis
Enterprise
Trade
reports
rights
Adani Portfolio maintains double-digit growth, achieves record EBITDA for 12 months ending Dec'24
double-digit growth despite external challenges. For the twelve-month period ending December 2024, EBITDA reached Rs 86,789 crore, marking a 10.1 per cent year-on-year growth. Adjusted for prior income, the growth stands at 21.3 per cent. In the December quarter alone, EBITDA rose 17.2 per cent to Rs 22,823 crore, a company statement said. A key to this growth is the emerging businesses under Adani Enterprises, including solar and wind manufacturing and airports.
20.02 / 10:21
markets
Provident
Bill
reports
rights
mountaineering
Big dampener for "outsiders" seeking to buy agri land in Uttarakhand
Uttarakhand has made most districts out of bounds for «outsider» agriculturalists and horticulturalists. TheUttarakhand cabinet on February 20 approved a draft legislation that prohibits individuals from other states from acquiring agricultural and horticultural land in 11 of its 13 districts, with Haridwar and Udham Singh Nagar being the exceptions, ToI's Kautilya Singh reported. This legislative initiative is intended to «protect the state's resources, cultural heritage, and the rights of its citizens.» The bill is anticipated to be presented during the ongoing Budget session.
20.02 / 08:37
markets
Death
reports
rights
Iran executed 975 people in 'horrifying' 2024 escalation: Human rights groups
human rights groups said on Thursday.
20.02 / 06:07
markets
Ball
Analysis
economy
Trade
President
rights
Tariff threats: What will happen if the other side does not play ball the way President Trump wants to? Arvind Sanger explains
Arvind Sanger, Managing Partner, Geosphere Capital Management, says Trump's threats of tariffs are just the starting point in negotiations, not the final goal. Because of this, the market continues to rise. Another interesting point is that this year's rally isn't just fueled by the Magnificent 7. It's much more widespread. This is a positive sign, indicating a general sense of economic optimism rather than just focusing on those seven companies and ignoring the rest. What will the US President do next, no one knows. I at least do not know. Do you? Arvind Sanger: None of us know, but the market has correctly been rising because the bet is that at the end of the day, Trump's tariff threats are a negotiating tool. They are not a tool to destroy the US economy because eventually tariffs hurt everybody. So, the market is making the bet that deregulation is coming, taxes are going to stay low. The one area where I worry is that there is a hope that maybe there will be a lot of cost savings from DOGE and Elon Musk, and I am not sure how much they will be able to extract, but there is some hope that there will be something there.
20.02 / 06:07
markets
UPS
FIVE
Analysis
wellness
Trade
rights
Market correction offering long-term investors a golden opportunity: Manish Chokhani
«I remember all of us from the markets were in this very famous now, Jaipur Jamboree in December and the mood was also quite unanimous over there that the markets have run far ahead of themselves,» says Manish Chokhani, Director, Enam Holdings. The markets have taken a nasty knock. Everybody knew that this was coming. It is just that when it hit us, nobody was prepared for it. Manish Chokhani: Yes, it is true. Even I never thought that we have a bubble in the market, because the largecaps actually had not really participated. And the bubble we used to always talk of was occurring in the smallcaps and the SME type IPOs and that is where the pain has obviously been the maximum and earnings have dramatically slowed down.
20.02 / 05:51
20.02 / 05:51
markets
Analysis
trends
Trade
reports
rights
Updates
Stock market update: Nifty IT index falls 0.15% in a weak market
Infosys Ltd.(up 0.78 per cent), L&T Technology Services Ltd.(up 0.65 per cent), MphasiS Ltd.(up 0.27 per cent) and Persistent Systems Ltd.(up 0.02 per cent) were among the top gainers.
20.02 / 05:19
markets
UPS
Analysis
economy
Trade
rights
Rupee rises 19 paise to 86.79 against US dollar in early trade
foreign fund outflow is weighing on investor sentiments. At the interbank foreign exchange, the rupee opened at 86.88 and gained further ground to trade at 86.79 against the greenback during early deals, up 19 paise from its previous close.
20.02 / 05:19
markets
Analysis
wellness
Cummins
Trade
Experts
rights
Market’s pain nearing its end; expect revival in broader market: Hemang Jani
«At the same time, I do think that we have underperformed big time and there is too much of focus on these FIIs sell flows and when exactly it will end,» says Hemang Jani, Independent Market Expert. A little hopeful with the recovery in the broader markets yesterday. Do you think we are closer to the end of the pain for the overall market fall? Hemang Jani: I do not think Nifty has been finding some sort of support around these levels. Though we do see a bit of volatility here and there, but there is a by and large comfort in the indices like Nifty and Bank Nifty. After a long time, we have seen a bit of a revival come through in the broader market midcaps and smallcaps where the pain was there for past many days.
20.02 / 05:19
markets
Analysis
Trade
reports
rights
Updates
Pharmaceuticals
Stock market update: Nifty Pharma index falls 0.17% in a weak market
Gland Pharma Ltd.(up 1.61 per cent), Cipla Ltd.(up 1.1 per cent), Lupin Ltd.(up 0.49 per cent), Zydus Lifesciences Ltd.(up 0.26 per cent) and Glenmark Pharmaceuticals Ltd.(up 0.1 per cent) were among the top gainers.
frequently asked questions about rights
What is rights and why is it gaining attention?
Rights is a trending topic that interests a wide audience. On our site, we regularly publish updates related to this subject.
Where can I find the latest updates on rights?
All latest articles about rights can be found in the dedicated section. We publish information regularly.
How can I verify the accuracy of information on rights?
We consult with professionals to ensure that the information about rights is reliable and valuable for our readers.